From the genetics of ankylosing spondylitis to new biology and drug target discovery
Genome-wide association studies (GWAS) have identified 113 single nucleotide polymorphisms (SNPs) affecting the risk of developing ankylosing spondylitis (AS), and an on-going GWAS study will likely identify 100+ new risk loci. The translation of genetic findings to novel disease biology and treatme...
Autors principals: | Zaarour, N, Li, Y, Shi, H, Bowness, P, Chen, L |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
Frontiers Media
2021
|
Ítems similars
-
OVERVIEW OF ANKYLOSING SPONDYLITIS GENETICS AND PATHOGENESIS
per: Bowness, P
Publicat: (2012) -
GM-CSF primes proinflammatory monocyte responses in Ankylosing Spondylitis
per: Shi, H, et al.
Publicat: (2020) -
The immunology of Ankylosing Spondylitis
per: Bowness, P
Publicat: (2011) -
New developments in our understanding of Ankylosing Spondylitis pathogenesis
per: Voruganti, A, et al.
Publicat: (2020) -
Discovery of candidate serum proteomic and metabolomic biomarkers in ankylosing spondylitis.
per: Fischer, R, et al.
Publicat: (2012)